Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia

NCT ID: NCT06353698

Last Updated: 2024-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-02

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate The effect of fasting mimicking diet with chemotherapy on the number of blasts and platelets and quality of life in patients with acute lymphoid leukemia and acute myeloid leukemia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this clinical trial is to investigate The effect of fasting mimicking diet with chemotherapy on the number of blasts and platelets and quality of life in patients with acute lymphoid leukemia and acute myeloid leukemia

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fasting Mimicking Diet Leukemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fasting mimicking diet

the intervention group that receive fasting mimicking diet with chemotherapy

Group Type EXPERIMENTAL

fasting mimicking diet

Intervention Type DIETARY_SUPPLEMENT

Fasting mimicking diet is limited calorie diet to enhance the effectiveness of chemotherapy

control

the control group that receive chemotherapy without any intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fasting mimicking diet

Fasting mimicking diet is limited calorie diet to enhance the effectiveness of chemotherapy

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People who have recently been diagnosed with acute leukemia pathology and have been prescribed chemotherapy

* Willingness to cooperate
* BMI \>18.5

Exclusion Criteria

* diabetes
* metastases to other organ
* Unwillingness to continue the study by patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Nutrition and Food Technology Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Azita Hekmatdoost

Principle Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ehsan Hejazi, PhD

Role: PRINCIPAL_INVESTIGATOR

Beheshti University of Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azita Hekmatdoost

Tehran, Middle East, Iran

Site Status RECRUITING

Ehsan Hejazi

Tehran, , Iran

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ehsan Hejazi, PhD

Role: CONTACT

00989121530775

Azita Hekmatdoost

Role: CONTACT

009123065084

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Azita Hekmatdoost, MD, PhD

Role: primary

+989123065084

Ehsan Hejazi, PhD

Role: primary

00989121530775

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nnftri

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.